(Q39580020)

English

Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.

scientific article published on 7 March 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Jian-Hua Yin

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Wei-Dong Shi

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Xiao-Yan Zhu

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Zhen Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Lu-Ming Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

7 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Integrative Cancer Therapies

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

37-47

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Adjuvant 5-FU-based chemoradiotherapy for patients undergoing R-1/R-2 resections for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Modulation of the organ microenvironment for treatment of cancer metastasis

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Type IV collagenases in invasive tumors

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Matrix metalloproteinases in tumor-host cell communication

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Cyr61 promotes breast tumorigenesis and cancer progression

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Resistance to targeted therapy in renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F1534735411400315

21 January 2018

Identifiers

10.1177/1534735411400315

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39580020&oldid=1521344443"